Rachel Katz, MD, BS
Assistant Professor of PsychiatryCards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Co-Director - Transcranial Magnetic Stimulation (TMS) Service, Psychiatry
Contact Info
Interventional Psychiatry Service
184 Liberty Street
New Haven , CT 06519
United States
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Co-Director - Transcranial Magnetic Stimulation (TMS) Service, Psychiatry
Contact Info
Interventional Psychiatry Service
184 Liberty Street
New Haven , CT 06519
United States
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Co-Director - Transcranial Magnetic Stimulation (TMS) Service, Psychiatry
Contact Info
Interventional Psychiatry Service
184 Liberty Street
New Haven , CT 06519
United States
About
Copy Link
Titles
Assistant Professor of Psychiatry
Co-Director - Transcranial Magnetic Stimulation (TMS) Service, Psychiatry
Biography
Dr. Katz completed her undergraduate studies at Northwestern University, completing a bachelor of science in religion and communication studies with a focus in dance technique and pre-medical studies. She completed her medical degree at Case Western University, where she was elected to the Alpha Omega Alpha Honor Medical Society. She is currently an Assistant Professor of Clinical Psychiatry, with a focus in Interventional Psychiatry and Mood Disorders at Yale Psychiatric Hospital.
Appointments
Psychiatry
Assistant ProfessorPrimary
Other Departments & Organizations
- Interventional Psychiatry Service
- Psychiatry
- Yale Depression Research Program
- Yale Medicine
Education & Training
- Fellow - Interventional Psychiatry
- Yale New Haven Hospital (2018)
- Resident
- Yale New Haven Hospital (2017)
- Chief Resident - Interventional Psychiatry Service
- Yale New Haven Hospital (2017)
- MD
- Case Western Reserve University School of Medicine (2013)
- BS
- Northwestern University, Religion, Communication Sciences, Dance (2008)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Publications Timeline
Samuel Wilkinson, MD
Robert Ostroff, MD
Gerard Sanacora, PhD, MD
John Krystal, MD
Sina Nikayin, MD
Benjamin Cherry, MD, FACP
Publications
2025
Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine
Santucci M, Katz R, Pittman B, Nikayin S, Wilkinson S. Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine. Psychopharmacology 2025, 1-9. PMID: 40973876, DOI: 10.1007/s00213-025-06896-7.Peer-Reviewed Original ResearchCitationsConceptsQuick Inventory of Depressive Symptomatology-Self ReportDepressive disorderPsychiatric hospitalInventory of Depressive Symptomatology-Self ReportMontgomery-Asberg Depression Rating ScaleSample of treatment-seeking patientsHistory of psychiatric hospitalizationRapid-acting antidepressantsKetamine's antidepressant effectsDepression Rating ScaleExposure to electroconvulsive therapyTreatment-seeking patientsAssociated with differential clinical outcomesDose of lamotrigineMontgomery-AsbergAntidepressant effectsIntranasal esketamineUnipolar depressionElectroconvulsive therapyPsychiatric comorbiditiesKetamine/esketamineRating ScaleSample of patientsClinical outcomesAverage dose196. Lamotrigine is Not Associated With Differential Clinical Outcomes in a Real-World Sample of Patients With Unipolar Depression Receiving Ketamine/Esketamine
Santucci M, Pittman B, Katz R, Nikayin S, Wilkinson S. 196. Lamotrigine is Not Associated With Differential Clinical Outcomes in a Real-World Sample of Patients With Unipolar Depression Receiving Ketamine/Esketamine. Biological Psychiatry 2025, 97: s176. DOI: 10.1016/j.biopsych.2025.02.433.Peer-Reviewed Original ResearchKetamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians
Elliott S, B Katz R, B Ostroff R, Ansari M, Holmes S, Sanacora G. Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians. FOCUS The Journal Of Lifelong Learning In Psychiatry 2025, 23: 195-205. PMID: 40235610, PMCID: PMC11995899, DOI: 10.1176/appi.focus.20240040.Peer-Reviewed Original ResearchAltmetricConceptsTreatment-resistant depressionElectroconvulsive therapyCases of treatment-resistant depressionTreatment of depressionEfficacy of ketamineDepressive disorderSevere casesDepressionPatient selection criteriaPatient-specific factorsOptimal treatment choicePatient-specific considerationsKetamineStudy outcome measuresTreatment deliveryBenefit profileMeta-analysesTreatment choiceNoninferiority trialPublic health challengeEffective treatmentOutcome measuresGold standardUnique risksTherapy
2024
Safe Delivery of Electroconvulsive Therapy in a Patient With Obstructive Sleep Apnea and a Hypoglossal Nerve Stimulator: A Case Report.
Hughes M, Cohen T, Ostroff R, Katz R. Safe Delivery of Electroconvulsive Therapy in a Patient With Obstructive Sleep Apnea and a Hypoglossal Nerve Stimulator: A Case Report. J ECT 2024 PMID: 39589131, DOI: 10.1097/YCT.0000000000001089.Peer-Reviewed Case Reports and Technical Notes
2022
Prescribing non-pharmacologic interventions: the age of interventional psychiatry
Cahill J, Gallagher K, editors. Psychiatric Prescribing: The How, The Why and the Why Not. Cambridge: Cambridge University Press.Chapters
2020
Stress, Anxiety, or Depression? Treatment Starts with the Right Diagnosis.
Yale Medicine NewsPublications for non-academic audiences
2019
TMS Neuromodulation chapter
Yale Department of Psychiatry Manual of Interventional Psychiatry, accepted by Oxford PressChaptersThe Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion
Kitay BM, Katz RB, Wilkinson ST, Ostroff RB. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2019, 35: e4-e5. PMID: 29952859, PMCID: PMC6309946, DOI: 10.1097/yct.0000000000000516.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and Concepts
2018
The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders
Ostroff RB, Katz RB. The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders. Current Treatment Options in Psychiatry. June 2018, Volume 5, Issue 2, 228-241.ChaptersThe Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion
Kitay B, Katz R, Wilkinson S, Ostroff R. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2018, 1. DOI: 10.1097/00124509-900000000-99225.Peer-Reviewed Case Reports and Technical Notes
Academic Achievements & Community Involvement
Copy Link
Activities
activity West Haven VA
2024 - PresentPeer Review Groups and Grant Study SectionsMemberDetailsData Monitoring Safety Board: Safety, Tolerability, Electrophysiological Effects of Dimethyltryptamine (DMT) in Humans led by Cyril D’Souza MDactivity International Society for Electroconvulsive Therapy and Neuromodulation Education Committee
2024 - PresentProfessional OrganizationsCommittee Memberactivity Case Western Reserve University School of Medicine E-Journal, Psychiatry Edition
2012 - PresentJournal ServiceEditoractivity Nature
2024 - PresentJournal ServiceRevieweractivity Journal of ECT
2018 - PresentJournal ServiceReviewer
Honors
honor Distinguished Women in Medicine - 100 Years of Women at Yale School of Medicine
05/01/2020Yale School of Medicine AwardDetailsUnited Stateshonor Ira Levine Award
05/01/2015Yale University AwardYale Department of PsychiatryDetailsUnited Stateshonor Alpha Omega Alpha (AOA) Honor Medical Society
05/01/2013National AwardDetailsUnited Stateshonor Leah M. Dickstein Women in Psychiatry Award
05/01/2012Regional AwardCase Western Reserve University School of MedicineDetailsUnited Stateshonor Dean's Summer Grant Awardee
05/01/2010Regional AwardCase Western Reserve UniversityDetailsUnited States
Clinical Care
Copy Link
Overview
Rachel Katz, MD, is a psychiatrist who specializes in interventional psychiatry and mood disorders.
Dr. Katz focuses on diagnosing and treating various mental health conditions, including depression and anxiety, using advanced techniques to improve patient outcomes. She employs a range of approaches to manage these conditions, such as transcranial magnetic stimulation (TMS) and other therapeutic interventions.
An assistant professor of psychiatry at Yale School of Medicine, Dr. Katz received her medical training from Case Western Reserve University School of Medicine.
Clinical Specialties
Board Certifications
Psychiatry
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2017
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
Copy Link
News
Get In Touch
Copy Link
Contacts
Interventional Psychiatry Service
184 Liberty Street
New Haven , CT 06519
United States